학술논문

Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’: Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79–87
Document Type
Erratum
Source
In Annals of Oncology August 2020 31(8):1094-1094
Subject
Language
ISSN
0923-7534